DWS Health and Wellness Fund
DWS Health and Wellness Fund reported 64 holdings worth US$232M as of May 31, 2026 (Form N-PORT)
As of May 31, 2026 · Filed Jul 24, 2026
DWS Health and Wellness Fund reported 64 holdings worth US$232M as of May 31, 2026. Largest: Eli Lilly And Company, Johnson & Johnson and Unitedhealth Group Incorporated. Filed Jul 24, 2026 (Form N-PORT).
- Holdings
- 64
- Value as reported
- US$232M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 29,054 | US$32.1M | 13.9% |
| Johnson & Johnson | 63,685 | US$14.4M | 6.2% |
| Unitedhealth Group Incorporated | 34,923 | US$13.3M | 5.7% |
| Abbvie Inc. | 52,180 | US$11.4M | 4.9% |
| Merck & Company, Inc. | 94,719 | US$11.2M | 4.9% |
| Astrazeneca Plc | 47,473 | US$8.81M | 3.8% |
| Thermo Fisher Scientific Inc | 16,298 | US$8.03M | 3.5% |
| Novartis Ag | 44,794 | US$6.71M | 2.9% |
| Amgen Inc. | 19,793 | US$6.67M | 2.9% |
| Gilead Sciences, Inc. | 47,850 | US$6.43M | 2.8% |
| Intuitive Surgical, Inc. | 14,659 | US$6.22M | 2.7% |
| Stryker Corporation | 19,804 | US$6.04M | 2.6% |
| Vertex Pharmaceuticals Incorporated | 12,681 | US$5.68M | 2.4% |
| Abbott Laboratories | 64,801 | US$5.55M | 2.4% |
| Danaher Corporation | 27,038 | US$4.94M | 2.1% |
| Boston Scientific Corporation | 101K | US$4.87M | 2.1% |
| Mckesson Corporation | 6,400 | US$4.75M | 2.0% |
| Novo Nordisk A/s Class B | 89,401 | US$4.02M | 1.7% |
| Medtronic Plc. | 48,488 | US$3.58M | 1.5% |
| Bristol-myers Squibb Company | 60,816 | US$3.48M | 1.5% |
| Regeneron Pharmaceuticals, Inc. | 5,385 | US$3.31M | 1.4% |
| Cardinal Health, Inc. | 15,800 | US$3.11M | 1.3% |
| Cencora, Inc. | 10,814 | US$2.91M | 1.3% |
| Roche Holding Ltd | 6,800 | US$2.87M | 1.2% |
| Pfizer, Inc. | 103K | US$2.71M | 1.2% |
| Agilent Technologies, Inc. | 19,806 | US$2.68M | 1.2% |
| Argenx Se | 2,823 | US$2.36M | 1.0% |
| Biogen Inc. | 11,150 | US$2.19M | 0.94% |
| Alnylam Pharmaceuticals, Inc. | 7,001 | US$2.11M | 0.91% |
| Iqvia Holdings, Inc. | 11,400 | US$2.08M | 0.90% |
| Edwards Lifesciences Corporation | 21,596 | US$1.87M | 0.81% |
| Neurocrine Biosciences, Inc. | 11,537 | US$1.83M | 0.79% |
| Alcon Ag | 27,497 | US$1.82M | 0.79% |
| Becton, Dickinson And Company | 12,200 | US$1.79M | 0.77% |
| Resmed Inc. | 9,347 | US$1.78M | 0.77% |
| Idexx Laboratories, Inc. | 3,089 | US$1.74M | 0.75% |
| Dexcom, Inc. | 22,908 | US$1.69M | 0.73% |
| Sanofi Sa | 19,096 | US$1.66M | 0.72% |
| West Pharmaceutical Services, Inc. | 5,015 | US$1.62M | 0.70% |
| Waters Corporation | 4,191 | US$1.61M | 0.69% |
| Zoetis Inc. | 19,156 | US$1.49M | 0.64% |
| Radnet, Inc. | 24,997 | US$1.39M | 0.60% |
| Centene Corporation | 21,174 | US$1.26M | 0.54% |
| Incyte Corporation | 12,579 | US$1.22M | 0.52% |
| Ge Healthcare Technologies Inc. | 19,500 | US$1.22M | 0.52% |
| Natera, Inc. | 4,500 | US$1.01M | 0.43% |
| Humana Inc. | 3,116 | US$952K | 0.41% |
| Veeva Systems Inc. | 5,218 | US$910K | 0.39% |
| Labcorp Holdings Inc. | 3,490 | US$908K | 0.39% |
| Privia Health Group, Inc. | 41,332 | US$889K | 0.38% |
| Insmed Incorporated | 8,239 | US$881K | 0.38% |
| Biomarin Pharmaceutical Inc. | 14,842 | US$850K | 0.37% |
| Insulet Corporation | 5,332 | US$773K | 0.33% |
| Illumina, Inc. | 4,691 | US$764K | 0.33% |
| Essilorluxottica Sa | 3,400 | US$695K | 0.30% |
| Sandoz Group Ltd | 8,203 | US$690K | 0.30% |
| United Therapeutics Corporation | 1,200 | US$668K | 0.29% |
| Globus Medical, Inc. | 8,100 | US$663K | 0.29% |
| The Cooper Companies, Inc. | 10,700 | US$655K | 0.28% |
| Bio-techne Corp | 9,200 | US$475K | 0.21% |
| Repligen Corporation | 3,200 | US$397K | 0.17% |
| Eyepoint, Inc. | 21,900 | US$297K | 0.13% |
| Baxter International Inc. | 0 | US$0 | 0.00% |
| Apellis Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related